TP53 and cervical carcinoma: combined a cervical cancer cell line expressing recombinant Cas9 with an AAV-sgE6 vector and observed in vitro that E6 genomic sequences were mutated, expression diminished, p53 expression increased, apoptosis was enhanced, and cellular proliferation was restrained in a concentration-related fashion.